Bain Capital Tech Opportunities invests $150M in Axtria at ~$1B

What's the deal? In May 2021, Berkeley Heights, New Jersey–based life-sciences commercial analytics SaaS Axtria secured a $150 million growth investment from Bain Capital Tech OpportunitiesDealroom has a profile for this one. Try Dealroom →. Contemporary press reported a valuation of about $1 billion .

What they do: Cloud software and data analytics for pharma/life-sciences commercial operations (sales, marketing, market access).

Later capital: In September 2025 Axtria announced a separate strategic investment with Kedaara Capital (employee share buy-back) — distinct from the Bain round.

Bain angle: Healthcare IT / application software growth check under BCTO.

Source: Axtria press release; Bloomberg reporting on valuation.